URI
59
3
VNO
59
2
VTR
46
2
BIIB
50
5
AXP
73
4
MAC
55
4
CAT
48
2
GILD
64
2
KLAC
70
9
MUR
33
4
PRU
59
5
HRB
55
3
TXT
70
2
FIS
67
2
LNC
40
4
FTI
64
3
LMT
60
3
XOM
42
2
MA
71
2
AMZN
64
4
URI
59
3
VNO
59
2
VTR
46
2
BIIB
50
5
AXP
73
4
MAC
55
4
CAT
48
2
GILD
64
2
KLAC
70
9
MUR
33
4
PRU
59
5
HRB
55
3
TXT
70
2
FIS
67
2
LNC
40
4
FTI
64
3
LMT
60
3
XOM
42
2
MA
71
2
AMZN
64
4
Financhill
Back

ProShares Ultra FTSE Europe Vs. Akero Therapeutics Industry Stock Comparison

Sell
50

UPV
ProShares Ultra FTSE Europe

Last Price:
$78.02
Seasonality Move:
-1.15%
Buy
68

AKRO
Akero Therapeutics

Last Price:
$54.26
Seasonality Move:
26.74%
Sell
50
ProShares Ultra FTSE Europe (UPV) is a Sell

Is ProShares Ultra FTSE Europe a Buy, Sell or Hold?

  • The current ProShares Ultra FTSE Europe [UPV] share price is $78.23. The Score for UPV is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • UPV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
68
Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $54.28. The Score for AKRO is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

UPV Stock Price Chart

What is ProShares Ultra FTSE Europe's stock price today?

  • The ProShares Ultra FTSE Europe share price today is $78.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UPV is experiencing slight buying pressure.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $54.28
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.

UPV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.24 Buy
Relative Strength Index (14 RSI): 67.01 Buy
Chaikin Money Flow: 476 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (72.24 - 77.12) Buy
Bollinger Bands (100): (60.91 - 73.15) Buy

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.09 Buy
Relative Strength Index (14 RSI): 70.44 Buy
Chaikin Money Flow: -1219058 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.53 - 50.43) Buy
Bollinger Bands (100): (34.89 - 51.35) Buy

UPV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 77.11 Buy
20-day SMA: 75.45 Buy
50-day SMA: 69.37 Buy
200-day SMA: 64.73 Buy
8-day EMA: 77.21 Buy
20-day EMA: 75.32 Buy
50-day EMA: 71.56 Buy
200-day EMA: 65.59 Buy

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.82 Buy
20-day SMA: 46 Buy
50-day SMA: 42.47 Buy
200-day SMA: 36.08 Buy
8-day EMA: 51.3 Buy
20-day EMA: 47.76 Buy
50-day EMA: 44.57 Buy
200-day EMA: 37.75 Buy

ProShares Ultra FTSE Europe Earnings Growth & UPV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.

ProShares Ultra FTSE Europe Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):